itraconazole and Multiple Myeloma

itraconazole has been researched along with Multiple Myeloma in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (40.00)29.6817
2010's8 (53.33)24.3611
2020's1 (6.67)2.80

Authors

AuthorsStudies
Atsriku, C; Gaudy, A; Liu, L; MacGorman, K; Palmisano, M; Surapaneni, S; Xue, Y; Ye, Y1
Das, S; Gu, Z; Levasseur, D; Shi, J; Tolomelli, G; Tricot, G; Wang, H; Xia, J; Xu, H; Yang, Y; Zhan, F; Zhou, W; Zhou, Y1
Eluvathingal, T; Fogel, B; Kothari, A; Mohan, M; Schinke, C1
Che, FF; Cheng, J; Huang, XB; Shi, Y; Wang, CS; Wang, XD1
Burgaleta, C; Cuadros, JA; García-Suárez, J; Gómez-Herruz, P; Guillén, H1
Gu, JL; Huang, BH; Li, J; Liu, JR1
Fujieda, A; Ishibashi, M; Iwamoto, T; Katayama, N; Masuya, M; Okuda, M1
Abumiya, M; Kameoka, Y; Miura, M; Sawada, K; Takahashi, N1
Hashimoto, N; Hattori, Y; Kato, J; Koda, Y; Mori, T; Okamoto, S; Sadahira, K; Shimizu, T; Tsukada, Y; Yamane, A; Yokoyama, K1
Hashimoto, N; Okamoto, S; Sadahira, K; Tsukada, Y; Ueda, T; Yokoyama, K1
Alvareda, D; Silva, V; Zepeda, G1
Anagnostopolous, I; Gleissner, B; Schilling, A; Siehl, I; Thiel, E1
Gutin, PH; Holodny, A; Prabhakaran, S; Raizer, JJ1
Asaka, M; Imamura, M; Kahata, K; Kato, N; Ota, S; Tanaka, J; Toubai, T; Toyoshima, N; Umehara, S1
Ascioglu, S; Casassus, P; De Pauw, B; Denning, DW; Herbrecht, R; Lortholary, O; Marinus, A; Moreau, P1

Reviews

1 review(s) available for itraconazole and Multiple Myeloma

ArticleYear
Improved outcome of zygomycosis in patients with hematological diseases?
    Leukemia & lymphoma, 2004, Volume: 45, Issue:7

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Deoxycholic Acid; Ethmoid Sinusitis; Female; Hematologic Diseases; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Liposomes; Lymphoma, Large B-Cell, Diffuse; Male; Maxillary Sinusitis; Middle Aged; Mucor; Mucormycosis; Multiple Myeloma; Nose Diseases; Opportunistic Infections; Prognosis; Treatment Outcome; Zygomycosis

2004

Trials

1 trial(s) available for itraconazole and Multiple Myeloma

ArticleYear
Evaluation of iberdomide and cytochrome p450 drug-drug interaction potential in vitro and in a phase 1 study in healthy subjects.
    European journal of clinical pharmacology, 2021, Volume: 77, Issue:2

    Topics: Adult; Area Under Curve; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Healthy Volunteers; Heterocyclic Compounds, 4 or More Rings; Humans; Immunologic Factors; Itraconazole; Lupus Erythematosus, Systemic; Male; Microsomes, Liver; Middle Aged; Morpholines; Multiple Myeloma; Phthalimides; Piperidones; Rifampin; Young Adult

2021

Other Studies

13 other study(ies) available for itraconazole and Multiple Myeloma

ArticleYear
RARα2 expression confers myeloma stem cell features.
    Blood, 2013, Aug-22, Volume: 122, Issue:8

    Topics: Animals; Cell Line, Tumor; Cell Survival; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Humans; Isoxazoles; Itraconazole; Mice; Multidrug Resistance-Associated Proteins; Multiple Myeloma; Neoplastic Stem Cells; Plasma Cells; Prognosis; Proto-Oncogene Proteins c-bcl-2; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Signal Transduction; Sulfones; Syndecan-1; Veratrum Alkaloids; Wnt Proteins

2013
Gastrointestinal histoplasmosis in a patient after autologous stem cell transplant for multiple myeloma.
    Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; beta-Glucans; Colonoscopy; Fever; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Hematopoietic Stem Cell Transplantation; Histoplasma; Histoplasmosis; Humans; Ileum; Intestinal Obstruction; Itraconazole; Lymphadenopathy; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Weight Loss

2016
[Synergistic Inhibitory Effect of Arsenic Trioxide Combined with Itraconazole on Hedgehog Pathway of Multiple Myeloma NCI-H929 Cells].
    Zhongguo shi yan xue ye xue za zhi, 2016, Volume: 24, Issue:5

    Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Hedgehog Proteins; Humans; Itraconazole; Mice; Multiple Myeloma; Oxides; Signal Transduction

2016
Rhodotorula mucilaginosa catheter-related fungaemia in a patient with multiple myeloma.
    Mycoses, 2011, Volume: 54, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Catheter-Related Infections; Echinocandins; Fungemia; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Multiple Myeloma; Rhodotorula; Treatment Outcome

2011
[The clinical features and risk factors for invasive fungal infection in multiple myeloma.].
    Zhonghua nei ke za zhi, 2009, Volume: 48, Issue:12

    Topics: Antifungal Agents; Humans; Itraconazole; Multiple Myeloma; Mycoses; Risk Factors

2009
Drug interaction between itraconazole and bortezomib: exacerbation of peripheral neuropathy and thrombocytopenia induced by bortezomib.
    Pharmacotherapy, 2010, Volume: 30, Issue:7

    Topics: Adult; Aged; Boronic Acids; Bortezomib; Clinical Trials as Topic; Dexamethasone; Drug Interactions; Female; Humans; Itraconazole; Japan; Male; Middle Aged; Multiple Myeloma; Peripheral Nervous System Diseases; Pyrazines; Retrospective Studies; Secondary Prevention; Thrombocytopenia; Treatment Outcome

2010
Drug interaction between lenalidomide and itraconazole.
    American journal of hematology, 2012, Volume: 87, Issue:3

    Topics: Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dexamethasone; Female; Humans; Intestinal Absorption; Itraconazole; Lenalidomide; Melphalan; Middle Aged; Multiple Myeloma; Neutropenia; Prednisone; Thalidomide

2012
[Early onset of paralytic ileus caused by simultaneous administration of bortezomib and azole antifungals in multiple myeloma patients].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2012, Volume: 53, Issue:8

    Topics: Aged; Antifungal Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Interactions; Drug Therapy, Combination; Humans; Intestinal Pseudo-Obstruction; Itraconazole; Middle Aged; Multiple Myeloma; Mycoses; Pyrazines; Pyrimidines; Triazoles; Voriconazole

2012
Itraconazole may increase the risk of early-onset bortezomib-induced peripheral neuropathy.
    International journal of hematology, 2012, Volume: 96, Issue:6

    Topics: Adult; Aged; Antifungal Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Cytochrome P-450 Enzyme System; Dexamethasone; Diabetes Complications; Drug Synergism; Female; Humans; Inactivation, Metabolic; Incidence; Itraconazole; Male; Middle Aged; Multiple Myeloma; Mycoses; Opportunistic Infections; Peripheral Blood Stem Cell Transplantation; Peripheral Nervous System Diseases; Protease Inhibitors; Proton Pump Inhibitors; Pyrazines; Retrospective Studies; Risk Factors; Salvage Therapy

2012
[Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
    Revista iberoamericana de micologia, 2003, Volume: 20, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Chile; Communicable Diseases, Emerging; Cross Infection; Drug Resistance, Fungal; Fatal Outcome; Fluconazole; Humans; Immunocompromised Host; Intensive Care Units; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Multiple Myeloma; Mycoses; Opportunistic Infections; Parkinson Disease; Postoperative Complications; Trichosporon; Urinary Catheterization; Urinary Tract Infections; Ventriculoperitoneal Shunt

2003
Isolated primary intracerebral mycetoma: presenting as a mass lesion in a patient with prostate cancer and multiple myeloma.
    Journal of neuro-oncology, 2005, Volume: 71, Issue:1

    Topics: Aged; Amphotericin B; Antifungal Agents; Brain Neoplasms; Central Nervous System Fungal Infections; Diagnosis, Differential; Humans; Itraconazole; Magnetic Resonance Imaging; Male; Mitosporic Fungi; Multiple Myeloma; Mycetoma; Neoplasm Metastasis; Prostatic Neoplasms; Treatment Outcome

2005
[Itraconazole capsules as antifungal prophylaxis for neutropenic patients with hematological malignancies from a single institution].
    The Japanese journal of antibiotics, 2005, Volume: 58, Issue:6

    Topics: Adolescent; Adult; Aged; Capsules; Drug Interactions; Female; Humans; Itraconazole; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Mycoses; Neutropenia; Prospective Studies

2005
Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: a European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the Intergroupe Français du Myélome.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 30, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Europe; Female; Humans; Itraconazole; Male; Middle Aged; Multiple Myeloma; Opportunistic Infections; Retrospective Studies; Transplantation, Homologous; Treatment Outcome

2000